We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Ebolavirus Nucleoprotein Suggested as Possible Drug Target

By LabMedica International staff writers
Posted on 19 Apr 2015
Print article
Image: A protein — shown in red, white, and blue — typically coats the genome of the Ebolavirus, providing protection from enzymes that can destroy the virus’s genetic material. This protein coat is removed to allow the virus to replicate its genome in infected cells. Interfering with the removal and the return of the protein coat to the viral genome can kill the Ebola virus, a discovery that opens the door to more effective treatments (Photo courtesy of Washington University School of Medicine).
Image: A protein — shown in red, white, and blue — typically coats the genome of the Ebolavirus, providing protection from enzymes that can destroy the virus’s genetic material. This protein coat is removed to allow the virus to replicate its genome in infected cells. Interfering with the removal and the return of the protein coat to the viral genome can kill the Ebola virus, a discovery that opens the door to more effective treatments (Photo courtesy of Washington University School of Medicine).
A team of molecular virologists has isolated and characterized a peptide from Ebolavirus (EBOV) that is critical to the pathogen's ability to reproduce inside infected cells.

Ebola is an RNA virus whose nucleic acid package is covered with a protective nucleoprotein (NP) coat. NP alternates between an RNA-template-bound form and a template-free form to provide the viral polymerase access to the RNA template. In addition, newly synthesized NP must be prevented from indiscriminately binding to nonviral RNAs.

Investigators at the Washington University School of Medicine (St. Louis, MO, USA) have explained the molecular bases for these critical processes in a paper published in the April 9, 2015, online edition of the journal Cell Reports. They reported the identification of an intrinsically disordered peptide derived from EBOV VP35 nucleoprotein (NPBP, residues 20–48) that bound to NP with high affinity and specificity, inhibited NP oligomerization, and released RNA from NP-RNA complexes in vitro.

X-ray crystallography analysis at a resolution of 3.7 Angstroms revealed that NPBP peptide occluded a large surface area that was important for NP-NP and NP-RNA interactions and for viral RNA synthesis. This peptide represented a highly conserved viral interface that was important for EBOV replication and could be targeted for therapeutic development.

“One of the major challenges was that the part of VP35 involved in this interaction is an intrinsically disordered peptide,” said first author Dr. Daisy Leung, assistant professor of pathology and immunology at Washington University Medical School. “This means that it may not take on a definite structure until it binds to another protein. That made structural studies of VP35 difficult because the structure, which plays a critical role in determining function, does not form without its specific binding partner.”

Related Links:

Washington University School of Medicine


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: ColoSense is the first FDA-approved RNA-based molecular screening test for qualitative detection of colorectal cancer (Photo courtesy of Geneoscopy)

RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer

Colorectal cancer (CRC) ranks as the second most lethal cancer in the United States. Nevertheless, many Americans eligible for screening do not undergo testing due to limited access or reluctance towards... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more